Method and compositions for regulation of 5-alpha reductase activity
Patent 6696484 Issued on February 24, 2004. Estimated Expiration Date: April 24, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
514/456, Bicyclo ring system having the hetero ring as one of the cyclos (e.g., chromones, etc.)514/337, The additional hetero ring is one of the cyclos in a polycyclo ring system514/453, Polycyclo ring system having the hetero ring as one of the cyclos514/455, Chalcogen bonded directly to ring carbon of the hetero ring514/457, Coumarins (including hydrogenated)514/532, Z-C(=O)-O-Y, wherein Z contains a benzene ring514/544, C(=O)O attached directly through the carbon to a benzene ring514/557, Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.)514/558, Higher fatty acid or salt thereof514/617, R contains benzene ring514/622, C-O- group in R514/646, Benzene ring containing514/655, The aryl ring or aryl ring system and amino nitrogen are bonded directly to the same acylic carbon, which carbon additionally has only hydrogen or acyclic hydrocarbyl substituents bonded directly thereto514/678, Benzene ring containing514/679, Plural rings514/680, Polycyclo ring system514/681, Bicyclo514/682, Naphthyl ring system514/683, Alicyclic ring514/720, Acyclic carbon to carbon unsaturation514/729, Alicyclic ring containing514/731, C of C-O- group is nuclear C of a benzene ring (e.g., phenol, phenolate, etc.)514/732Polycyclo ring system (e.g., naphthols, etc.)
Pharmaceutical compositions and methods for treating androgen related disorders. The pharmaceutical compositions may include a 5-reductase inhibitor, such as natural and synthetic flavanoids, catechols, curcumin-related substances, quinones, catechins, particularly epigallocatechin derivatives, fatty acids, and the salts, esters, analogues, pro-drugs, isomers, racemic mixtures, or derivatives of any of the foregoing. The use of testosterone (or DHT) combinations with the aforementioned 5-reductase inhibitor compounds is also contemplated.
Other References
Asai, et al., "Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue," J. Nutr, 2001, 131(11):2932-5
Bhattacharyya et al., "Analysis of the steroid binding domain of rat steroid 5 alpha-reductase (isozyme-1) the steroid D-ring binding domain of 5 alpha-reductase," Steroids, 1999; 64: 197-204
Donadio, James V., "Omega-3 polyunsaturated fatty acids: a potential new treatment of immune reanl disease," Mayo Clin Proc, May 1991: 1018-1028
Downing, et al., "Essential fatty acids and acne," J Am Acad Dermatrol, 6; May 1986: 221-5
Frost, et al., "Inhibitors of sex hormones: development of experiment modes", Adv. Biol. Skin., May 1972: 403-420
Harris, et al., "Identification oand selective inhibition of an isozyme of steroid 5 alpha-reductase in human scalp," Prc. Natl. Acad. Sci. USA, May 1992: 10787-1079
Hiipakka, et al., "Structure-activity relationship for inhibition of human 5 alpha-reductase by polyphenols," Biochem Pharmacol. Mar. 15, 2002;63(6): 1165-76
Hiipakka, et al., "Expression of 5 alpha-reductase in bacteria as a trp E fusion protein and its use in the production of antibodies for immunocytochemical localization of 5 alpha reductase," J Steroid Biochem Mol Biol. Jun. 1993;45(6): 539-48
Igarashi, Miki and Miyazawa, Teruo, "The growth inhiitory effect of conjugated linoliec acid on a human hepatoma cell line, HepG2, is induced by achange in fatty acid metabolism, but not the facilitation of lipid peroxidation in the cells," Biochem Biophys Acta. Feb. 26, 2001;1530(2-3): 162-71
Kao, et al., "Modulation of obesity by a green tea catechin," Am J Clin Nutr. Nov. 2000;72(5): 1232-4
Horrobin, et al., "Essential fatty acids in clinical dermatology," J Am Acad Dermatol. Jun. 1989; 20(6):1045-53
Khan, et al., "Arachidonic and cis-unsaturated fatty acids induce selective platelet substrate phosphorylation through activation of cytosolic protein kinase C," FEBS Lett. Nov. 4, 1991;292(1-2):98-102
Komori, et al., "Anticarcinogenic activity of green tea polyphenols," Jpn J Clin Oncol. Jun. 1993;23(3):186-90
Liang, et al., "Inhibition of testosterone stimulation of the hamster flank organs by y-linolenic acid a five alpha-reductase inhibitor," SID Abstracts, vol. 102 (No. 4), 647
Liang, et al., "Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human," Endocrinology. Aug. 1985;117(2):571-9
Liang, Techming and Liao, Shutsung, "Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids," Biochem J. Jul. 15, 1992;285 (Pt 2):557-62
Liang, et al., "Anti-5 alph-reductase autoantibodies in the serum of patients with prostatic cancer," J Clin Endocrinol Metab. Dec. 1990;71(6):1666-8
Liang, et al., "Growth suppression of hamster flank organs by topical application of y-linolenic and other fatty acid inhibitors of 5 alpha-reductase," J Invest Dermatol. Aug. 1997:109(2):152-7
Liao, et al., "Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate," Cancer Lett. Sep. 25, 1995;96(2):239-43
Liao, S, "The medicinal action of androgens and green tea epigallocatechin gallate," Hong Kong Med J. Dec. 2001;7(4): 369-74
Liao, et al., "Growth suppression of hamster flank organs by topical application of catechins, alizarin, curcumin, and myristoleic acid," Arch Dermatol Res. Apr. 2001;293(4): 200-5
Shutsung, Liao, "Androgen action: Molecular mechanism and medical application," J Formos Med Assoc. Sep. 1994;93(9): 741-51
Liao, et al., "Selective inhibition of steroid 5 alpha-reductase isozymes by tea ipicatechin-3-gallate and epicallocatechin-3-gallate," Biochem Biophys Res Commun. Sep. 25, 1995;214(3):833-8
Liao, et al., "Green tea: Biochemical and biological bais for health benefits," Vitam Horm. 2001;62:1-94
Miyazawa, Teruo, "Absorption, metabolism and antioxidative effects of tea catechin in humans," Biofactors. 2000;13(1-4):55-9
Nagata, et al., "Association of coffee, green tea, and caffine intakes with serum concentrations of estriadiol and sex hormone-binding globulin in premenopausal japanese women,"Nutr Cancer. 1998;30(1):21-4
Rose, David and Connolly, Jeanne, "Effects of fatty acids and dicosanoid synthesi inhibitors on the growth of two human prostate cancer cell lines," Prostate. 1991;18(3):243-54
Rizvi, Syed and Zaid, Mohammad, "Modulation of erythrocyte membrane NA/K-Atpase activity by insulin in normal and type 2 diabetic patients. evaluation of the insulin-like role of (-)epicatechin," Medicinal Science Research. 1998. 26:245-247
Serafini, Paulo and Lobo, Rogerio, "Increased 5alpha-reductase activity in idiopathic hirsutism," Fertil Steril. Jan. 1985;43(1): 74-8
Tang, et al., "Green tea polyphenols and vitamin e inhibit angogenesis by supressing il-8," Free Radic Biol Med. 1999. 27: S149
Taylor, et al., "Photoaffinity labeling or rat steroid 5alpha-reductase (isozyme-1) by a benzophenone derivative of a 4-methyl-4-azasteroid," Steroids. May 1996;61(5) :323-31
Umekita, et al., "Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride," Proc Natl Acad Sci U S A. Oct. 15, 1996;93(21):11802-7
Valcic, et al., "Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines," Anticancer Drugs. Jun. 1996;7(4):461-8
Yang, Chung and Wang, Zhi-Yuan, "Tea and cancer," J Natl Cancer Inst. Jul. 7, 1993;85(13):1038-49
Zhu, et al., "Effects of tea polyphenols and flavonoids on liver microsomal glucuronidation of estradiol and estrone," J Steroid Biochem Mol Biol. Feb. 1998;64(3-4):207-15
Chantre P. and Lairon D., "Recent findings of green tea extract AR25 (exolise and its activity for the treatment of obesity," Phytomedicine (jena), Jan. 2002; 9(1); 3-8
Sartippour, et al., "Green tea and its catechins inhibit breast cancer xenografts," Nutrition and Cancer. 2001; 40 (2);149-156
Proniuk, et al., "Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention." J. Pharm Sci. Jan. 2002; 91; 111-6
Kao, et al., "Modulation of endocrine systems and food intake by green tea epigallocatechin gallate". Endocrinology, 2000, 141 (3): 980-987
Fujiki, et al., Green Tea: Cancer Preventive Beverage and/or Drug, Cancer Letters, vol. 188, pp. 9-13 (2002)
Le Marchand, Cancer Preventive Effects of Flavonoids--A Review, Biomed Pharmacother, vol. 56, pp. 296-301 (2002)
Lou, et al., Effects of Topical Applications of Caffeine or (-)--Epigallocatechin Gallate (EGCG) on Skin Carcimogenesis and Apoptosis in SKH-1 Hairless Mice Previously Treated with Ultraviolet B Light (High Risk Mice), Proceedings of the American Association for Cancer Research, vol. 43, p. 1143 (Mar. 2002)
Ahmed, et al., Differential Modulation of Growth and Glutathione Metabolism in Cultured Rat Astrocytes by 4-Hydroxynonenal and Green Tea Polyphenol, Epigallocatechin-3-Gallate, Neuro Toxicology, vol. 23, pp. 289-300 (2002)
Cai, et al., Contribution of Presystemic Hepatic Extraction to the Low Oral Bioavailability of Green Tea Catechins in Rats, Drug Metabolism and Disposition, vol. 30, pp. 1246-1249 (2002)
Soleas, et al., A Comparison of the Anticarcinogenic Properties of Four Red Wine Polyphenols, Clinical Biochemistry, vol. 35, pp. 119-124 (2002)
Proniuk, et al., Preformulation Study of Epigallocatechin Gallate, a Promising Antioxidant for Topical Skin Cancer Prevention, Journal of Pharmaceutical Sciences, vol. 91, No. 1, pp. 111-116 (Jan. 2002)
Getie, et al., Evaluation of the Release Profiles of Flavonoids from Topical Formulations of the Crude Extract of the Leaves of Dodonea Viscosa (Sapindaceae), Pharmazie, vol. 57, pp. 320-322 (2002)
Wang, et al., Gene Expression Profile in Human Prostate LNCaP Cancer Cells by (-) Epigallocatechin-3-Gallate, Cancer Letters, vol. 182, pp. 43-51 (2002)
Greenway, Non-Pharmacologic Treatment of Obesity: Herbal Aids to Weight Loss, International Journal of Obesity, S185, No. 693
Tea Offers Myriad Health Benefits, www.msnbc (downloaded Sep. 27, 2002)
Gupta, et al., Inhibition of Prostate Carcinogenesis in TRAMP Mice by Oral Infusion of Green Tea Polyphenols, PNAS, vol. 96, No. 18 (Aug. 28, 2001)
Kao, et al., Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocate Gallate, Endocrinology, vol. 141, No. 3, pp. 980-987 (2000)
Dulloo, Reply to Y-H Kao, et al., The American Journal of Clinical Nutrition, vol. 72, No. 5, pp. 1233-34 (Nov. 2000)
Dulloo, et al., Efficacy of a Green Tea Extract Rich in Catechin Polyphenols and Caffeine in Increasing 24-h Energy Expenditure and Fat Oxidation in Humans, American Journal of Clinical Nutrition, vol. 70, No. 6, pp. 1040-45 (Dec. 1999)
Chantre, et al., Recent Findings of Green Tea Extract AR25 (Exolise) and its Activity for the Treatment of Obesity, Phytomedicine, vol. 9, pp. 3-8 (2002)
Dulloo, et al., Green Tea and Thermogenesis: Interactions Between Catechin-Polyphenols, Caffeine and Sympathetic Activity, International Journal of Obesity Related Metabolic Disorders, vol. 24, No. 2, pp. 252-8 (Feb. 2000) [Abstract]
Miyazawa, Absorption, Metabolism and Antioxidative Effects of Tea Catechin in Humans, BioFactors, vol. 13, pp. 55-59 (2000)
Nagata, et al., Association of Coffee, Green Tea, and Caffeine Intakes With Serum Concentrations of Estradiol and Sex Hormone-Binding Globulin in Premenopausal Japanese Women, Nutrition and Cancer, vol. 30, No. 1, pp. 21-24 (1998)
Tang, et al., Green Tea Polyphenols and Vitamin E Inhibit Angiogenesis by Suppressing IL-8, Oxygen, S149, No. 456 (1999)
Komori, et al., Anticarcinogenic Activity of Green Tea Polyphenols, Japanese Journal of Clinical Oncology, vol. 23, No. 3, pp. 186-190 (1993)
Green Tea Inhibits Factor Linked to Vessel Growth in Cancer, www.Bioexchange.com (Downloaded Nov. 1, 2002)
Asai, et al., Dietary Curcuminoids Prevent High-Fat Diet-Induced Lipid Accumulation in Rat Liver and Epididymal Adipose Tissue, J. Nutr., vol. 131, No. 11, pp. 2932-5 (Nov. 2001). [Abstract]
Nakagawa, et al., Dose-Dependent Incorporation of Tea Catechins, (-)-Epigallocatechin-3-Gallate and (-)-Epigallocatechin, Into Human Plasma, Biosci Biotechnol Biochem, vol. 61, No. 12, pp. 1981-5 (Dec. 1997). [Abstract]
Sartippour, et al., Green Tea and Its Catechins Inhibit Breast Cancer Xenografts, Nutrition and Cancer, vol. 40, No. 2, pp. 149-156 (2001)
Zhu, et al., Effects of Tea Polyphenols and Flavonoids on Liver Microsomal Glucuronidation of Estradiol and Estrone, J. Steroid Biochem. Molec. Biol., vol. 64, No. 3-4, pp. 207-215 (1998)
Yang, et al., Tea and Cancer, Journal of National Cancer Institute, vol. 85, No. 13, pp. 1038-1049 (Jul. 7, 1993)
Valcic, et al., Inhibitory Effect of Six Green Tea Catechins and Caffeine on the Growth of Four Selected Human Tumor Cell Lines, Anti-Cancer Drugs, vol. 7, pp. 461-468 (1996)
Umekita, et al., Human Prostate Tumor Growth in Athymic Mice: Inhibition by Androgens and Stimulation by Finasteride, Proc. Natl. Acad. Sci. USA, vol. 93, pp. 11802-11807 (Oct. 1996)
Liao, et al., Green Tea: Biochemical and Biological Basis for Health Benefits, Vitamins and Hormones, vol. 62, pp. 1-94 (2001)
Liao, et al., Selective Inhibition of Steroid 5-Reductase Isozymes by Tea Epicatechin-3-Gallate and Epigallocatechin-3-Gallate, Biochemical and Biophysical Research Communications, vol. 214, No. 3, pp. 833-838 (1995)
Liao, et al., Growth Suppression of Hamster Flank Organs by Topical Application of Catechins, Alizarin, Curcumin, and Myristoleic Acid, Arch Dermatol Res., vol. 293, pp. 200-205 (2001)
Liao, The Medicinal Action of Androgens and Green Tea Epigallocatechin Gallate, HKMJ, vol. 7, No. 4, pp. 369-374 (Dec. 2001)
Liao, et al., Growth Inhibition and Regression of Human Prostate and Breast Tumors in Athymic Mice by Tea Epigallocatechin Gallate, Cancer Letters, vol. 96, pp. 239-243 (1995)
Willett, Modulation of Obesity by a Green Tea Catechin, Am. J. Clin. Nutr., vol. 72, pp. 1232-1235 (2000)
Hiipakka, et al., Structure-Activity Relationships for Inhibition of Human 5-Reductase by Polyphenols, Biochemical Pharmacology, vol. 63, pp. 1165-76 (2002)
Afaq, et al., Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate Inhibits Ultra-Violet B-Mediated Activation of Nuclear Factor kB in Cultured Human Epidermal Keratinocytes, Proceedings of the American Association for Cancer Research, vol. 43, p. 1143, No. 5665 (Mar. 2002)
April 24, 2022. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
